Gemayel Georges insider trades
Gemayel Georges has filed 22 Form 4s with the SEC that we hold, for Supernus Pharmaceuticals, INC. (SUPN) (Director) and Disc Medicine, Inc. (IRON) (Director). Across all of them we count 0 purchases worth $0 and 6 sales worth $2.3M reported on Form 4. In the last 12 months: 0 purchases ($0) and 2 sales ($1.0M). The largest single trade was a sale of 10,000 shares of Supernus Pharmaceuticals, INC. worth $537.1K, dated 2026-03-05. The first filing on our record is dated 2021-11-16 and the latest 2026-06-23.
Supernus Pharmaceuticals, INC. (SUPN)
| Trade date | Code | Shares | Value as filed | Filed |
|---|---|---|---|---|
| 2024-09-13 | S, sale reported on Form 4 | 3,886 | $121.7K | 2024-09-17 |
| 2024-09-13 | S, sale reported on Form 4 | 10,000 | $313.3K | 2024-09-17 |
| 2024-11-07 | S, sale reported on Form 4 | 14,213 | $520.5K | 2024-11-08 |
| 2024-11-08 | S, sale reported on Form 4 | 10,787 | $391.6K | 2024-11-12 |
| 2026-03-05 | S, sale reported on Form 4 | 10,000 | $537.1K | 2026-03-09 |
| 2026-03-06 | S, sale reported on Form 4 | 8,787 | $465.7K | 2026-03-09 |
Disc Medicine, Inc. (IRON)
No purchase or sale of common stock reported here; these filings cover grants, option exercises or other codes.
Counted from the Form 4 filings this reporting owner (SEC CIK 1256088) filed on EDGAR. Values are the transaction values as filed. See every filing on EDGAR, or browse insider buying and today's insider purchases.
Source: U.S. Securities and Exchange Commission (EDGAR) and other official
government data · Updated 2026-10-12 ·
For informational purposes only, not investment advice.
Privacy · Terms